Hypoxia promotes tumor growth in linking angiogenesis to immune escape.

Hypoxia promotes tumor growth in linking angiogenesis to immune escape.
复制标题

DOI:
10.3389/fimmu.2012.00021
复制
发表时间:
2012
影响因子:
7.3
通讯作者:
Noman MZ
Noman MZ
中科院分区:
医学2区
文献类型:
--
作者:
Chouaib S;Messai Y;Couve S;Escudier B;Hasmim M;Noman MZ

文献摘要

参考文献

被引文献

相似文献

尽管在过去的十年中,在肿瘤免疫学领域取得了令人印象深刻的进展,例如肿瘤抗原和抗原肽的鉴定,但在引发有效的免疫应答以根除癌症方面仍然存在许多障碍。越来越清楚的是,肿瘤微环境在免疫保护的控制中起着至关重要的作用。肿瘤已经进化到通过激活在进展、存活和转移中重要的关键生物化学和细胞途径来利用低氧应激以对其自身有利。缺氧诱导因子(HIF-1)和血管内皮生长因子(VEGF)在促进肿瘤细胞生长和存活中起决定性作用。缺氧通过激活HIF-1和VEGF途径促进免疫抑制。越来越多的证据表明,缺氧和肿瘤耐受性之间的联系,通过募集调节细胞(调节性T细胞和髓源性抑制细胞)的免疫监视。在这方面,缺氧(HIF-1α和VEGF)正在成为癌症治疗的一个有吸引力的靶点。微环境缺氧如何构成新的治疗性免疫干预的障碍和机会将进行讨论。
Despite the impressive progress over the past decade, in the field of tumor immunology, such as the identification of tumor antigens and antigenic peptides, there are still many obstacles in eliciting an effective immune response to eradicate cancer. It has become increasingly clear that tumor microenvironment plays a crucial role in the control of immune protection. Tumors have evolved to utilize hypoxic stress to their own advantage by activating key biochemical and cellular pathways that are important in progression, survival, and metastasis. Hypoxia-inducible factor (HIF-1) and vascular endothelial growth factor (VEGF) play a determinant role in promoting tumor cell growth and survival. Hypoxia contributes to immune suppression by activating HIF-1 and VEGF pathways. Accumulating evidence suggests a link between hypoxia and tumor tolerance to immune surveillance through the recruitment of regulatory cells (regulatory T cells and myeloid derived suppressor cells). In this regard, hypoxia (HIF-1α and VEGF) is emerging as an attractive target for cancer therapy. How the microenvironmental hypoxia poses both obstacles and opportunities for new therapeutic immune interventions will be discussed.
缺氧会增强乳腺癌中的 Notch 信号传导,导致 E-钙粘蛋白表达减少,细胞迁移和侵袭增加。
DOI: 10.1038/sj.bjc.6605486
发表时间: 2010-01-19
影响因子: 8.8
作者:
Chen, J.;Imanaka, N.;Chen, J.;Griffin, J. D.
通讯作者: Griffin, J. D.
DOI: 10.1038/nm1075
发表时间: 2004-08-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Ceradini, DJ;Kulkarni, AR;Gurtner, GC
通讯作者: Gurtner, GC
DOI: 10.1016/j.ccr.2005.09.005
发表时间: 2005-10-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Casanovas, O;Hicklin, DJ;Hanahan, D
通讯作者: Hanahan, D
DOI: 10.1038/nrc2442
发表时间: 2008-08
期刊: Nature reviews. Cancer
影响因子: --
作者:
通讯作者: --
DOI: 10.1056/nejmoa1104390
发表时间: 2011-12-29
影响因子: 158.5
作者:
Burger, Robert A.;Brady, Mark F.;Liang, Sharon X.
通讯作者: Liang, Sharon X.